Laduviglusib trihydrochloride
Product Specifications
CAS Number
1782235-14-6
Target
Autophagy, GSK-3, Wnt/beta-catenin
Related Pathways
Cytoskeletal Signaling, Stem Cells, PI3K/Akt/mTOR signaling, Autophagy
Purity
0.9934
Bioactivity
Laduviglusib trihydrochloride (CT99021 trihydrochloride) is a selective glycogen synthase kinase 3 (GSK-3) inhibitor with IC50s of 10 nM and 6.7 nM for GSK-3α and GSK-3β. Laduviglusib trihydrochloride inhibits human GSK-3β with a Ki of 9.8 nM. Laduviglusib trihydrochloride is an activator of Wnt/β-catenin signaling. Laduviglusib trihydrochloride induces autophagy.
Smiles
Cl.Cl.Cl.Cc1cnc([nH]1)-c1cnc(NCCNc2ccc(cn2)C#N)nc1-c1ccc(Cl)cc1Cl
Molecular Formula
C22H20Cl5N8
Molecular Weight
573.71
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![(R)-1-Azido-3-[[3-fluoro-4-(morpholin-4-yl)phenyl]amino]propan-2-ol](https://cdn.genprice.uk/products/572/4818839307782/imageurl/trc-a850155-5mg.webp)
TRC-A850155-5MG 5 mg
(R)-1-Azido-3-[[3-fluoro-4-(morpholin-4-yl)phenyl]amino]propan-2-ol
Sign In for Pricing
View Details 
BNC042406-500 1x 500 µL
Bcl-X (Apoptosis Marker) (BCL2L1/2406), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 